Depot Disulfiram for AIDS and ARC - Tabular View

Tracking Information
First Received Date ^ICMJE	November 2, 1999
Last Updated Date	June 23, 2005
Start Date ^ICMJE
Primary Completion Date
Current Primary Outcome Measures ^ICMJE
Original Primary Outcome Measures ^ICMJE
Change History	Complete list of historical versions of study NCT00002065 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE
Original Secondary Outcome Measures ^ICMJE

Descriptive Information
Brief Title ^ICMJE	Depot Disulfiram for AIDS and ARC
Official Title ^ICMJE	Depot Disulfiram for AIDS and ARC
Brief Summary	To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.
Detailed Description
Study Phase
Study Type ^ICMJE	Interventional
Study Design ^ICMJE	Treatment, Open Label
Condition ^ICMJE	HIV Infections
Intervention ^ICMJE	Drug: Disulfiram
Study Arms / Comparison Groups
Publications *
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE
Completion Date
Primary Completion Date
Eligibility Criteria ^ICMJE	Inclusion Criteria Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria. Also patient must be: Able to understand the study. Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms. Ambulatory and able to maintain an independent life outside the hospital. Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. History of alcohol abuse.
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	United States

Administrative Information
NCT ID ^ICMJE	NCT00002065
Responsible Party
Study ID Numbers ^ICMJE	024A
Study Sponsor ^ICMJE	St. Vincent's Medical Center
Collaborators ^ICMJE
Investigators ^ICMJE
Information Provided By	NIH AIDS Clinical Trials Information Service
Verification Date	November 1999
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP